Forward Citations = 10

Loading Chart...

5 inventors (with patents filed for the assignee):

John Patrick Maxwell (8 out of 48 patents)

Kevin M Cottrell (7 out of 7 patents)

Douglas A Whittington (3 out of 3 patents)

4. David Joseph Guerin (1 out of 27 patents)

5. Xinyuan Edward Wu (1 out of 22 patents)

8 patents: Sort by Forward Citations

1. 12403137 - Compounds and methods of use (2025-09-02),

2. 12304907 - Compounds and methods of use (2025-05-20),

3. 12264154 - Compounds and methods of use (2025-04-01),

4. 12043607 - HDAC inhibitors and therapeutic use thereof (2024-07-23),

5. 11999727 - Compounds and methods of use (2024-06-04),

6. 11986471 - Compounds and methods of use (2024-05-21),

7. 11492350 - Compounds and methods of use (2022-11-08),

8. 11077101 - Compounds and methods of use (2021-08-03),

Company Overview

Tango Therapeutics is a biotechnology company focused on discovering and developing targeted cancer therapies. Through their unique approach to precision medicine, they aim to identify and exploit vulnerabilities in cancer cells to create more effective and personalized treatments. With a team of experienced researchers and industry experts, Tango Therapeutics is committed to making a meaningful impact on the lives of cancer patients.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

8 Patents

#273 in Cambridge, MA

#2,098 in Massachusetts

#35,924 in US

Cambridge, MA, United States of America

Tango Therapeutics, Inc.

Forward Citations = 10

5 inventors:

John Patrick Maxwell (8 out of 48 patents)

Kevin M Cottrell (7 out of 7 patents)

Douglas A Whittington (3 out of 3 patents)

4. David Joseph Guerin (1 out of 27 patents)

5. Xinyuan Edward Wu (1 out of 22 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tango Therapeutics, Inc.. Retrieved from https://idiyas.com/company/tango-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]